BGB-23339

DRUG2 trials

Sponsors

BeiGene

Conditions

Healthy VolunteersNot Determined

Phase 1

First-in-Human, Single- and Multiple-Ascending Dose and Food-Effect Study of BGB-23339 in Healthy Participants

CompletedNCT05093270

BeiGeneNot Determined

Start: 2021-11-15End: 2022-12-26Updated: 2025-09-22

Safety, Tolerability, and Pharmacokinetics of BGB-23339 in Healthy Japanese and Caucasian Subjects

WithdrawnNCT05387668

BeiGeneHealthy Volunteers

Start: 2022-02-17End: 2022-10-17Updated: 2022-12-16